{"id":690451,"date":"2013-03-19T10:12:27","date_gmt":"2013-03-19T04:42:27","guid":{"rendered":"http:\/\/stockviz.biz\/index.php\/?p=690451"},"modified":"2013-03-19T10:23:10","modified_gmt":"2013-03-19T04:53:10","slug":"analysis-lupin-2","status":"publish","type":"post","link":"https:\/\/stockviz.biz\/index.php\/2013\/03\/19\/analysis-lupin-2\/","title":{"rendered":"Analysis: LUPIN"},"content":{"rendered":"<p>Today\u2019s pick is LUPIN [stockquote]LUPIN[\/stockquote]. The stock has been on an uptrend since the start of the year. It reached its 52 week\u2019s high of Rs. 622 in the month of September. It is currently under long term pennant formation. In the last three months, the stock moved <b>+2<strong>%<\/strong><\/b> vs. a flat Nifty.<\/p>\n<p><a title=\"LUPIN Technical Analysis Chart\" href=\"http:\/\/stockviz.biz\/StockDive?TICKER=LUPIN\"><img loading=\"lazy\" decoding=\"async\" style=\"margin: 10px;padding-left: 0px;padding-right: 0px;padding-top: 0px;border: 0px\" title=\"LUPIN Technical Analysis Chart\" alt=\"LUPIN Technical Analysis Chart\" src=\"http:\/\/portalvhds29z8xdrqhczq.blob.core.windows.net\/wordpress\/2013\/03\/STOCK.LUPIN2013-03-19.png\" width=\"602\" height=\"482\" border=\"0\" \/><\/a><\/p>\n<p>Oscillator <a href=\"http:\/\/stockviz.biz\/index.php\/part-ix-relative-strength-index-rsi\/\">RSI<\/a> and <a href=\"http:\/\/stockviz.biz\/index.php\/technical-trading\/chande-momentum-oscillator\/\">CMO<\/a> are currently in no-man\u2019s land. The stock is currently trading in the upper range of the <a href=\"http:\/\/stockviz.biz\/index.php\/2012\/07\/27\/bollinger-bands\/\">Bollinger band<\/a>s. Short-term technical just saw a 9X18 <b>bullish<\/b> cross-over.<\/p>\n<p>The <a href=\"http:\/\/stockviz.biz\/index.php\/part-xi-moving-average-convergence-divergence-macd2\/\">MACD<\/a> line has bullishly penetrated the signal line after very long. However, the Long-term and short-term <a href=\"http:\/\/stockviz.biz\/index.php\/technical-trading\/guppy-multiple-moving-averages\/\">GMMA<\/a> lines are moving very close to each other without giving any directional bias to the stock.<\/p>\n<p><a title=\"LUPIN Correlation chart\" href=\"http:\/\/stockviz.biz\/StockDive?TICKER=LUPIN\"><img loading=\"lazy\" decoding=\"async\" style=\"margin: 10px;padding-left: 0px;padding-right: 0px;padding-top: 0px;border: 0px\" title=\"LUPIN Correlation chart\" alt=\"LUPIN Correlation chart\" src=\"http:\/\/portalvhds29z8xdrqhczq.blob.core.windows.net\/wordpress\/2013\/03\/cor.LUPIN2013-03-19.png\" width=\"630\" height=\"210\" border=\"0\" \/><\/a><\/p>\n<p>LUPIN\u2019s average <a href=\"http:\/\/stockviz.biz\/index.php\/tag\/correlation\/\">correlation<\/a> with the <a href=\"http:\/\/stockviz.biz\/Technicals.aspx?INDEX=NIFTY\">Nifty<\/a> is <b>0.29,<\/b> which is <b>positive<\/b>. The scrip will be replicating movement of Nifty. [stockquote]NIFTYBEES[\/stockquote]<\/p>\n<p><a title=\"LUPIN Volatility chart\" href=\"http:\/\/stockviz.biz\/StockDive?TICKER=LUPIN\"><img loading=\"lazy\" decoding=\"async\" style=\"margin: 10px;padding-left: 0px;padding-right: 0px;padding-top: 0px;border: 0px\" title=\"LUPIN Volatility chart\" alt=\"LUPIN Volatility chart\" src=\"http:\/\/portalvhds29z8xdrqhczq.blob.core.windows.net\/wordpress\/2013\/03\/Vol.LUPIN2013-03-19.png\" width=\"630\" height=\"210\" border=\"0\" \/><\/a><\/p>\n<p>LUPIN has a historical <a href=\"http:\/\/stockviz.biz\/index.php\/2012\/07\/17\/understanding-volatility-part-i\/\">volatility<\/a> in the narrow range of 0.2 to 0.7. The scrip\u2019s volatility is currently in the lower end of the range.<\/p>\n<p>Given the technicals, we suggest a short-term<b> buy<\/b>. A long-term call could be taken depending on the directional break-out of the pennant. Also, it is advisable to have a relaxed <a href=\"http:\/\/stockviz.biz\/index.php\/2012\/10\/09\/setting-trailing-stop-loss-percentages\/\">trailing stop-losses<\/a> level to book profits in case of a trend-reversal.<\/p>\n<h6 class=\"zemanta-related-title\" style=\"font-size: 1em\">Related articles<\/h6>\n<ul class=\"zemanta-article-ul zemanta-article-ul-image\" style=\"margin: 0px;padding: 0px;overflow: hidden\">\n<li class=\"zemanta-article-ul-li-image zemanta-article-ul-li\" style=\"margin: 2px 10px 10px 2px;padding: 0px;width: 84px;text-align: left;font-size: 11px;vertical-align: top;float: left\"><a style=\"padding: 2px;text-decoration: none\" href=\"http:\/\/stockviz.biz\/2013\/02\/21\/lupin-receives-usfda-nod-for-lorazepam-oral-concentrate\/\" target=\"_blank\"><img decoding=\"async\" style=\"margin: 0px;padding: 0px;border: 0px currentColor;width: 80px\" alt=\"\" src=\"http:\/\/i.zemanta.com\/147013304_80_80.jpg\" \/><\/a><a style=\"padding: 5px 2px 0px;height: 80px;line-height: 12pt;overflow: hidden;text-decoration: none\" href=\"http:\/\/stockviz.biz\/2013\/02\/21\/lupin-receives-usfda-nod-for-lorazepam-oral-concentrate\/\" target=\"_blank\">Lupin receives USFDA nod for Lorazepam Oral Concentrate<\/a><\/li>\n<li class=\"zemanta-article-ul-li-image zemanta-article-ul-li\" style=\"margin: 2px 10px 10px 2px;padding: 0px;width: 84px;text-align: left;font-size: 11px;vertical-align: top;float: left\"><a style=\"padding: 2px;text-decoration: none\" href=\"http:\/\/www.bloomberg.com\/news\/2013-03-12\/new-drugs-tempt-lupin-to-spend-up-to-1-billion-corporate-india.html\" target=\"_blank\"><img decoding=\"async\" style=\"margin: 0px;padding: 0px;border: 0px currentColor;width: 80px\" alt=\"\" src=\"http:\/\/i.zemanta.com\/151760938_80_80.jpg\" \/><\/a><a style=\"padding: 5px 2px 0px;height: 80px;line-height: 12pt;overflow: hidden;text-decoration: none\" href=\"http:\/\/www.bloomberg.com\/news\/2013-03-12\/new-drugs-tempt-lupin-to-spend-up-to-1-billion-corporate-india.html\" target=\"_blank\">New Drugs Tempt Lupin to Spend Up to $1 Billion: Corporate India &#8211; Bloomberg<\/a><\/li>\n<li class=\"zemanta-article-ul-li-image zemanta-article-ul-li\" style=\"margin: 2px 10px 10px 2px;padding: 0px;width: 84px;text-align: left;font-size: 11px;vertical-align: top;float: left\"><a style=\"padding: 2px;text-decoration: none\" href=\"http:\/\/news.in.msn.com\/business\/article.aspx?cp-documentid=252074966\" target=\"_blank\"><img decoding=\"async\" style=\"margin: 0px;padding: 0px;border: 0px currentColor;width: 80px\" alt=\"\" src=\"http:\/\/i.zemanta.com\/140408386_80_80.jpg\" \/><\/a><a style=\"padding: 5px 2px 0px;height: 80px;line-height: 12pt;overflow: hidden;text-decoration: none\" href=\"http:\/\/news.in.msn.com\/business\/article.aspx?cp-documentid=252074966\" target=\"_blank\">Lupin gets USFDA nod for generic oral contraceptive<\/a><\/li>\n<\/ul>\n<div class=\"zemanta-pixie\" style=\"height: 15px;margin-top: 10px\"><img decoding=\"async\" class=\"zemanta-pixie-img\" style=\"border: currentColor;float: right\" alt=\"\" src=\"http:\/\/img.zemanta.com\/pixy.gif?x-id=d6d3631d-4ac6-46a0-ac94-5ad645b0b2c2\" \/><\/div>\n<p> <\/p>\n<div style=\"height:200px;border-bottom: grey 1px solid;border-left: grey 1px solid;padding-bottom: 0px;padding-left: 10px;width: 100%;padding-right: 0px;border-top: grey 1px solid;border-right: grey 1px solid;padding-top: 0px\" class=\"roundedCornerSmall\">\n<div style=\"margin-top: 70px;float: left\"><a style=\"font-family: segoe ui;color: black;font-size: 18px;font-weight: 600\" href=\"http:\/\/stockviz.biz\/index.php\/2012\/11\/29\/the-stockviz-demat-account-2\/\">Open a StockViz Demat Account today!<\/a> <\/div>\n<div style=\"float: right\"><a href=\"918026650232\"><img decoding=\"async\" style=\"border-right-width: 0px;border-top-width: 0px;border-bottom-width: 0px;border-left-width: 0px\" alt=\"call us qr code\" src=\"http:\/\/portalvhds29z8xdrqhczq.blob.core.windows.net\/web-static\/QR_CODE_DIRECT_CALL_634909979709728491.png\"><\/a> <\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Today\u2019s pick is LUPIN [stockquote]LUPIN[\/stockquote]. The stock has been on an uptrend since the start of the year. It reached its 52 week\u2019s high of Rs. 622 in the month of September. It is currently under long term pennant formation. In the last three months, the stock moved +2% vs. a flat Nifty. Oscillator RSI &hellip; <\/p>\n","protected":false},"author":4,"featured_media":690481,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[623,815],"class_list":["post-690451","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-your-money","tag-lupin","tag-technical-analysis","entry"],"_links":{"self":[{"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/posts\/690451","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/comments?post=690451"}],"version-history":[{"count":0,"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/posts\/690451\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/media\/690481"}],"wp:attachment":[{"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/media?parent=690451"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/categories?post=690451"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stockviz.biz\/index.php\/wp-json\/wp\/v2\/tags?post=690451"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}